FDA’s Oncology Center of Excellence published a Request for Applications for projects focused on applied regulatory science research to understand factors that affect the safety and efficacy of underrepresented populations in oncology therapeutic development.
To access this subscriber-only content please log in or renew your subscription.
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe